Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

A user traveled from Canada to Chandigarh, India, for a hair transplant at Dr. Tejinder Bhatti's Darling Buds clinic and is pleased with the natural-looking results. The user feels happy and confident with the outcome.

Current treatments like finasteride, minoxidil, and derma rolling are considered the best for hair loss, while new treatments such as GT20029, PP405, and others are in various trial phases with results expected in the coming years. There is cautious optimism about the affordability and effectiveness of these upcoming treatments.

A 16-year-old is experiencing hair loss and is using minoxidil, finasteride, and plans to add RU58841, while considering other treatments like MK-677 and microneedling. Concerns are raised about the potential impact of these treatments on puberty and development.

The user experienced hair loss after chikungunya and started PRF (platelet-rich fibrin) injections with injectable Dutasteride, noticing new hair growth. They are hopeful for continued improvement.

User received Trichotest results not recommending Finasteride. They are on Oral Minoxidil 2.50 and considering adding Finasteride.

A user shared their experience with hair transplant success and stopping finasteride due to side effects like brain fog. They are content with potential hair loss and prioritize health over hair maintenance.

Pelage is recruiting for phase 2 trials, showing promise for treating bald regions. The discussion highlights its potential effectiveness based on its mechanism of action.

Adding tretinoin to a regimen of minoxidil and finasteride led to increased hair shedding and worsened hairline for some users. Opinions vary, with some experiencing negative effects and others seeing no issues, but concerns about tretinoin's impact on hair loss are common.

The conversation discusses the delay in the PP405 Phase 2 study results, now expected by the end of 2025, and skepticism about research practices. There is also mention of optimism for Amplifica's AMP303 and a topical treatment in early testing.

Lab-grown hair using iPSCs is being explored, but practical applications are limited. Finasteride is suggested as the only current effective treatment.